Utilizing Meal Replacements in Conjunction with GLP-1 Agonists
Presented by Mekhala Chandra, MD
As the use of weight loss medications continues to rise, nutritionally-designed meal replacements will help patients maintain a balanced diet and aid in healthy weight loss by ensuring necessary nutrition and caloric intake. What’s more, meal replacements ensure weight loss is happening at a sustainable pace while on medications such as semaglutide. During this 15-minute presentation, Mekhala Chandra, MD, will take a look at the reduction of mean energy intake in patients using GLP-1 agonists, and outline suggestions for filling in dietary gaps.
Learning Objectives Include:
- Understand that GLP-1 agonist medications are on the rise but are also known to reduce estimated mean energy intake
- Know how nutritional meal replacements can support a healthy metabolism while actively losing weight for patients on these anti-obesity medications
- Understand how meal replacements are an important adjunct to these medications to support and maintain healthy nutrition
ABOUT THE SPEAKER:
Dr. Mekhala Chandra is an Internal medicine board and Obesity medicine certified physician that received her medical degree from BVP University, Pune in India and completed her residency from California Pacific Medical Center, San Francisco in 2016. She practices hospital-based medicine, works as a consultant, and is a frequent contributor to various media outlets. She has a deep interest in the identification and treatment of metabolic disease and how this condition contributes to increased morbidity and mortality.
ABOUT THE HOST: Hundreds of nationally recognized hospitals and physicians trust Robard’s medically-supervised programs and nutrition products to successfully treat patients with obesity. To learn more, visit us online at www.Robard.com, email us at info@robard.com, or call (800) 222-9201.